| Literature DB >> 30707547 |
Abstract
Credit should be granted to medicinal chemists with a solid background in organic chemistry and computational chemistry, able to read, understand, and discuss the biological data, in order to design new and more efficient therapeutic approaches for Alzheimer's disease.Entities:
Keywords: Alzheimer’s disease; Aβ hypothesis; disease-modifying therapy approach; multitarget small molecules; symptomatic-disease approach; tau hypothesis
Mesh：
Substances：
Year: 2019 PMID： 30707547 DOI： 10.1021/acschemneuro.9b00034
Source DB: PubMed Journal: ACS Chem Neurosci ISSN： 1948-7193 Impact factor: 4.418